Difference between revisions of "MEDICATION-AMIODARONE"

From NeuroRehab.wiki

(Imported from text file)
(Imported from text file)
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
<div>1. Class III anti-arrhythmic agent that prolongs conduction through atrial, nodal, ventricular tissue.<div>2. Reduces the frequency of stimuli reaching the ventricle without causing negative inotropic effects, increases coronary blood flow.</div><div>3. Indications: AF, atrial flutter, SVT, conscious VT, VT/VF refractory to defibrillation, prophylaxis for VT/VF.</div><div>4. SE: hypotension, bradycardia, heart block, thrombophlebitis. Common long-term SE: hypothyroidism.</div><div><br></div><div>DOSAGE</div><div>5. Give 300-450 mg every third DC shock.</div>
===== [[Summary Article|'''SUMMARY''']] =====
 
1. Class III anti-arrhythmic agent that prolongs conduction through atrial, nodal, ventricular tissue.
<br/>2. Reduces the frequency of stimuli reaching the ventricle without causing negative inotropic effects, increases coronary blood flow.
<br/>3. Indications: AF, atrial flutter, SVT, conscious VT, VT/VF refractory to defibrillation, prophylaxis for VT/VF.
<br/>4. SE: hypotension, bradycardia, heart block, thrombophlebitis. Common long-term SE: hypothyroidism.
<br/>
<br/>DOSAGE
<br/>5. Give 300-450 mg every third DC shock.


[[Category:Medication]]
[[Category:Medication]]
[[Category:Advanced Life Support]]
[[Category:Advanced Life Support]]

Latest revision as of 08:39, 30 December 2022

SUMMARY

1. Class III anti-arrhythmic agent that prolongs conduction through atrial, nodal, ventricular tissue.
2. Reduces the frequency of stimuli reaching the ventricle without causing negative inotropic effects, increases coronary blood flow.
3. Indications: AF, atrial flutter, SVT, conscious VT, VT/VF refractory to defibrillation, prophylaxis for VT/VF.
4. SE: hypotension, bradycardia, heart block, thrombophlebitis. Common long-term SE: hypothyroidism.

DOSAGE
5. Give 300-450 mg every third DC shock.